SMTL ID : 5ncz.1

mPI3Kd IN COMPLEX WITH inh1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.94 Å

Oligo State

monomer

Ligands

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 7 residues within 4Å: Chain A: D.679, Y.705, I.717, I.802, D.803, F.804 Ligands: 8TN.5 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:D.679, A:D.679, A:Y.705, A:D.803, A:F.804 EDO.2: 6 residues within 4Å: Chain A: P.650, K.671, I.717, I.802, D.803 Ligands: 8TN.5 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.671 EDO.3: 7 residues within 4Å: Chain A: P.63, Q.65, D.497, D.498, F.501, N.532, K.534 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.65, A:N.532, A:K.534 EDO.4: 5 residues within 4Å: Chain A: L.15, W.541, R.544, G.578, L.581 No protein-ligand interaction detected (PLIP)

1 x 8TN: 4-azanyl-6-[[(1~{S})-1-[6-[3-[(dimethylamino)methyl]phenyl]-3-methyl-5-oxidanylidene-[1,3]thiazolo[3,2-a]pyridin-7-yl]ethyl]amino]pyrimidine-5-carbonitrile(Non-covalent)

8TN.5: 18 residues within 4Å: Chain A: T.642, F.643, M.644, P.650, W.652, I.669, Y.705, I.717, E.718, V.719, V.720, S.723, D.724, T.725, M.792, I.802 Ligands: EDO.1, EDO.2 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:T.642, A:W.652, A:W.652, A:W.652, A:T.725, A:I.802 Hydrogen bonds: A:E.718, A:V.720 Salt bridges: A:D.724

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Perry, M.W.D. et al., Design and Synthesis of Soluble and Cell-Permeable PI3K delta Inhibitors for Long-Acting Inhaled Administration. J. Med. Chem. (2017)

Release Date

2017-06-21

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform